NCT00903630 arm group 2b4d67f3097a32cb7e8c4e1300f1be52 [clinicaltrials_resource:NCT00903630/arm-group/2b4d67f3097a32cb7e8c4e1300f1be52]
NCT00903630 arm group 2b4d67f3097a32cb7e8c4e1300f1be52 [clinicaltrials_resource:NCT00903630/arm-group/2b4d67f3097a32cb7e8c4e1300f1be52]
Bio2RDF identifier
NCT00903630/arm-group/2b4d67f3097a32cb7e8c4e1300f1be52
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 4d67f3097a32cb7e8c4e1300f1be52
description [clinicaltrials_vocabulary:description]
Patients treated with a combin ...... or primary peritoneal cancer.
identifier
clinicaltrials_resource:NCT00903630/arm-group/2b4d67f3097a32cb7e8c4e1300f1be52
title
NCT00903630 arm group 2b4d67f3097a32cb7e8c4e1300f1be52
@en
type
label
NCT00903630 arm group 2b4d67f3 ...... d67f3097a32cb7e8c4e1300f1be52]
@en